EM

Esakki Mani Paramasivan

Active Director Director DIN 10268571
DIN 10268571 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Esakki Mani Paramasivan

Data last updated:

Esakki Mani Paramasivan is a Director at Winhale Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10268571
Primary Designation Director
Industry Pharma
First Appointment 07 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20232023Active

Board colleagues of Esakki Mani Paramasivan

NameDINCompanyDesignation
Nithya10268570Winhale Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Winhale Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Esakki Mani Paramasivan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Esakki Mani Paramasivan

Esakki Mani Paramasivan currently holds 1 directorship: Winhale Pharmaceuticals Private Limited (Director, since 07 Aug 2023).

Esakki Mani Paramasivan was first appointed on 07 Aug 2023 as Director at Winhale Pharmaceuticals Private Limited.

The current boards of Esakki Mani Paramasivan's companies include Nithya (Winhale Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available